- Home
- KPRX vs LUCY Comparison
KPRX vs LUCY Comparison
Compare KPRX & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPRX | LUCY |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 7.7M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | KPRX | LUCY |
|---|---|---|
| Price | $2.14 | $1.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 37.4K | ★ 255.7K |
| Earning Date | 11-07-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,392,547.00 |
| Revenue This Year | N/A | $80.76 |
| Revenue Next Year | N/A | $210.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 53.22 |
| 52 Week Low | $1.77 | $1.29 |
| 52 Week High | $4.18 | $7.08 |
Technical Indicators
Market Signals| Indicator | KPRX | LUCY |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 40.20 |
| Support Level | $2.03 | $1.36 |
| Resistance Level | $2.23 | $1.43 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 80.56 | 20.52 |
Price Performance
Historical ComparisonAbout KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.